logo
Insurance company told to reimburse liver transplant cost of Medisep beneficiary at non-empanelled hospital

Insurance company told to reimburse liver transplant cost of Medisep beneficiary at non-empanelled hospital

THIRUVANANTHAPURAM: In a landmark ruling, the Permanent Lok Adalat for Public Utility Services has directed the Oriental Insurance Company to reimburse the cost borne by a Medisep beneficiary for liver transplant at a non-empanelled hospital. The complainant, a pensioner, was diagnosed with a chronic liver disease with hepatocellular carcinoma. He underwent a deceased donor liver transplant on July 8, 2022, at a private hospital in Thiruvananthapuram.
Though the Medisep scheme came into existence with effect from July 1, 2022, the insurance company had not published the list of empanelled hospitals then, the pensioner said in his complaint. The total hospital expenses was Rs 20,54,901. He also had a health insurance policy issued by New India Assurance. As the claim under Medisep was not allowed, he submitted a claim with New India Assurance and the latter remitted Rs 3,69,367 at the hospital. He paid the balance amount. However, due to chronic ailments, he was hospitalised two times again for which Rs 1,21,656 was spent. These claims too were rejected by Medisep.
The Additional Chief Secretary (Finance) submitted that the petitioner was not entitled to claim benefit for treatment at a non-empanelled hospital. Liver transplant was a planned procedure and not an emergency procedure (for which non-empanelled hospitals will be considered). The insurance company rejected the allegation that the list of empanelled hospitals was not published at the time.
The case was considered by the Lokpal bench comprising members V N Radhakrishnan and E Mohammed Shereef. The petitioner was represented by advocates S Reghukumar, P Babu and Threya J Pillai.
The Lokpal observed that the surgery was done in an emergency situation as there was no alternate option for the petitioner's survival. The insurance firm failed to empanel two private hospitals for transplant surgeries under Cluster-3 of the Medisep Scheme. At the time, the organ of a deceased donor was available only at the hospital where he sought treatment. Hence, the petitioner is entitled for the reimbursement of treatment expenses up to the package cost in Annexure-2 of the scheme. It directed the firm to pay Rs 18 lakh to the petitioner with 6% interest from April 18, 2023, and Rs 10,000 as costs.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Festive Spirit High, Mumbai Cops Enforce Road Safety With 10,051 E-Challans, Hospitals Remain On Alert
Festive Spirit High, Mumbai Cops Enforce Road Safety With 10,051 E-Challans, Hospitals Remain On Alert

News18

time2 hours ago

  • News18

Festive Spirit High, Mumbai Cops Enforce Road Safety With 10,051 E-Challans, Hospitals Remain On Alert

Last Updated: The challans were issued on Sunday for traffic violations such as riding without helmets, wrong-side driving, triple-seat riding, and over-speeding, amounting to over Rs 1.13 crore Mumbai's streets came alive on Sunday with the high-energy celebrations of Dahi Handi, where thousands of Govindas formed human pyramids across neighbourhoods to break the symbolic earthen pots. While the city's festive spirit soared, authorities ensured that safety and discipline remained top priorities. According to Mumbai Police, a total of 10,051 spot e-challans were issued during the day for traffic violations such as riding without helmets, wrong-side driving, triple-seat riding, and over-speeding. The total penalties amounted to over Rs 1.13 crore. Police officials said CCTV scanning is still underway, and more electronic challans are expected to follow. 'Our aim is not just enforcement but ensuring that citizens remain safe during the celebrations," a senior police officer noted. On the healthcare front, hospitals across the city reported 210 Govindas injured during pyramid formations and related festivities. Data shared by civic and government hospitals show that while many suffered minor injuries, most were treated promptly and discharged. Mumbai Town hospitals recorded 91 cases, with 60 still under treatment and 31 discharged. Eastern suburbs saw 45 injuries, of which only five remain under treatment. Western suburbs reported 74 cases, with just four still receiving medical care. Ambulances were stationed near major Dahi Handi venues, while hospitals remained on alert. Organisers had also been directed by authorities to ensure that safety nets, harnesses, and medical aid were made available at bigger events. For Mumbaikars, the day symbolised the city's unique blend of tradition, energy, and resilience. The sounds of dhol-tasha, the sight of pyramids reaching towards the matki, and the cheers of crowds painted a vibrant picture of Mumbai's festive pulse. At the same time, the vigilance of the police and medical teams underscored the importance of celebrating responsibly. Now, the big task ahead for Mumbai Police is the Ganesh festival starting from August 27. During the 10-day festival, several VVIPS visit Mumbai to seek blessings at the Siddhivinayak Temple and Lalbaug Raja Pandal. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Ineligible persons posted at drug rehab, de-addiction centres, finds DC
Ineligible persons posted at drug rehab, de-addiction centres, finds DC

Indian Express

time4 hours ago

  • Indian Express

Ineligible persons posted at drug rehab, de-addiction centres, finds DC

An inquiry conducted by the Deputy Commissioner (DC) of Tarn Taran has allegedly found a nexus involving officials and a private contracting firm for recruiting ineligible persons into the district's drug de-addiction and rehabilitation facilities through outsourced contracts. The border district is one of the worst affected by the problem of drug menace. DC Rahul has recommended registration of police case based on inquiry report. The complainant claimed that contract was allegedly awarded illegally by the then Deputy Medical Commissioner, Dr Ramandeep Singh Padda. 'The contractor Davinder Singh was allegedly running a nexus through which he and his associates prepared fake degrees and documents, collected large sums of money from people, and gave them jobs. In this scheme, Rs 5 lakh was taken for the post of counsellor, Rs 3 lakh for staff nurse, and Rs 2 lakh for data entry operator, despite the degrees being fake. In July 2023, the company allegedly collected Rs 6,000 from each person in the name of verification, without issuing any receipt. The documents of the company's director and those submitted by the company are alleged to be fake. At the time of awarding the contract, Dr Padda is alleged to have carried out no verification,' says complainant Harjinder Singh. The inquiry report states that Asian Advanced Development Pvt Ltd, contracted to provide manpower from July 1, 2023, to March 31, 2024, charged unlawful 'verification fees' and allegedly took bribes for recruitment. The company's manager and contractor, Davinder Singh, has been accused of concealing facts about the contract, failing to follow contractual terms, submitting incomplete or misleading records, and harassing employees who raised complaints. The report further adds that the then Deputy Medical Commissioner Dr Padda, now posted as Senior Medical Officer (SMO) at Sur Singh, is alleged to have colluded with the contractor by failing to scrutinise documents and by ignoring irregularities in the recruitment process. The report cites evidence that fake certificates were used to hire several outsourced employees, including counsellors and data entry operators. It also refers to a legal agreement dated August 16, 2023, which allegedly shows that Rs 26.86 lakh was collected for recruitment as bribe. Several other outsourced staff are suspected to have been appointed without proper verification. The Deputy Commissioner has recommended forwarding the matter to the Senior Superintendent of Police, Tarn Taran, for detailed investigation, describing it as a matter of criminal nature. In a letter dated July 28, 2025, the incumbent Deputy Medical Commissioner of Tarn Taran reported alleged false patient entries and misuse of Buprenorphine tablets at two state-run opioid assisted treatment (OOAT) centres in the district. Buprenorphine, a controlled substance under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, is intended to help individuals gradually withdraw from opioid dependence. However, health officials say that some addicts extract and inject the medicine for a more intense 'kick'.' 'These tablets are not available in the open market and are dispensed strictly through prescription under controlled medical supervision,' a senior health official said. 'They are primarily used in de-addiction centres as part of opioid substitution therapy.' In letter addressed to the Senior Medical Officers of Ghariyala and Khadoor Sahib, the Deputy Medical Commissioner said that inspections at the OOAT Centre in Kiratowal (CHC Ghariyala) on July 28, 2025, and the OOAT Centre in Khadoor Sahib on July 25, 2025, revealed 'serious irregularities' in patient records and the distribution of medicines. According to the official, when the previous week's records were reviewed, the number of patients at the centres did not match the number of entries made online. The letter alleges that staff were 'consistently making false entries' and misusing OOAT medicines. The matter had also been referred to the Deputy Commissioner and Senior Superintendent of Police, Tarn Taran, for further investigation and possible action against the staff involved. In this matter too the police investigation hasn't started yet. Besides, these irregularities, these centres also witnessed theft of Buprenorphine from OOAT centres. The most recent incident occurred on July 1 at the Bhagupur Drugli Rehabilitation and OOAT centre in Tarn Taran. According to officials, a thief broke into the premises but was apprehended on the spot by security personnel and handed over to the police. The police also registered an FIR against the accused for stealing the fan from the facility at the Sadar Patti police station. On February 2, 2025, staff at the community health centre (CHC) at Ghariala reported that the door of the OOAT centre was found broken. Upon inspection, they discovered that the box containing Buprenorphine medicines had been forcibly opened. As many as 296 tablets of 2 mg and 5,626 tablets of 0.4 mg were reported stolen, according to officials. On March 3, 2025, thieves again targeted the CHC Ghariala. Items stolen included an air conditioner, a camera, a fan, and 3,151 tablets of 2 mg buprenorphine, officials said. Further, on May 25, all the Buprenorphine tablets were stolen from the civil hospital in Ajnala. Another theft was reported on December 13, 2024, at the Aam Aadmi Clinic in Rattagudda village in Tarn Taran. In this case, one air conditioner and a tablet charger were reported missing.

Medistep Healthcare shares to list today. Here's what GMP suggests
Medistep Healthcare shares to list today. Here's what GMP suggests

Time of India

time4 hours ago

  • Time of India

Medistep Healthcare shares to list today. Here's what GMP suggests

Shares of Medistep Healthcare will debut on the NSE SME platform on Monday. The stock is commanding a strong grey market premium (GMP) of around 19%, suggesting healthy listing gains for investors. The Rs 16.10 crore IPO, which was open for subscription from August 8 to August 12, saw an overwhelming response, with an overall subscription of 382.14 times. The retail portion was subscribed to an exceptional 461.11 times, while Non-Institutional Investors (NII) subscribed 289.15 times. Priced at Rs 43 per share, the issue was entirely a fresh issue of 37.44 lakh shares. The company plans to utilise the proceeds for working capital, purchase of plant and machinery for expansion, and general corporate purposes. Incorporated in June 2023, Medistep Healthcare manufactures and trades a diverse range of products, including sanitary pads, nutraceuticals, pharmaceutical items, surgical supplies, and intimate care products. For FY25, the company reported revenue of Rs 49.66 crore and profit after tax of Rs 4.14 crore, reflecting growth of 27% and 25% respectively over FY24. Live Events While analysts note the company operates in a highly competitive and fragmented segment, the robust subscription figures and positive GMP signal strong investor appetite. All eyes will now be on the listing, where the stock is expected to debut at a healthy premium over the issue price. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store